Philippe Chambon Insider Profile
4 Followers
Philippe Chambon, Director at Oruka Therapeutics, holds 5.76M shares in Oruka Therapeutics (Ticker: ORKA), holds 1.15M shares in NxStage Medical (Ticker: NXTM), holds 7.55K shares in Auxilium (Ticker: AUXL).
Philippe Chambon's Trading History
| NXTMNxStage Medical | Apr 02, 2013 | ― | Uninformative Buy | ― | $34.60M | |
| AUXLAuxilium | May 25, 2011 | ― | Uninformative Sell | 472.76K | ― | |
| EPOCEpocrates | ― | ― | ― | ― | ||
| ORKAOruka Therapeutics | ― | Director | ― | $606.80M |
You May Also Like
Philippe Chambon insider profile FAQ
What is the percentage of profitable transactions made by Philippe Chambon?
The percentage of profitable transactions made by Philippe Chambon is 63%.
What is the average return per transaction made by Philippe Chambon?
The average return per transaction made by Philippe Chambon is 9.90%.
What stocks does Philippe Chambon hold?
Philippe Chambon holds: ORKA, NXTM, AUXL, EPOC stocks.
What was Philippe Chambon's most profitable transaction?
Philippe Chambon’s most profitable transaction was an Informative Buy of NXTM stock on September 15, 2010. The return on the trade was 37.70%.
What is Philippe Chambon's role in Oruka Therapeutics?
Philippe Chambon's role in Oruka Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.
